secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K/A
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001628280-23-001398
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neoleukin files corrected Amended and Restated Bylaws to fix table-of-contents errors
--------------------------------------------------------------------------------

- Board adopted amended bylaws on Nov 30, 2022.
- Corrected version filed on Jan 7, 2023, fixing incorrect references and page numbers in the table of contents.
- Correction addresses clerical errors only; substantive bylaws unchanged.
- Corrected bylaws attached as Exhibit 3.1 to this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000162828023001398/0001628280-23-001398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000162828023001398/nltx-20221130.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-001398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer